30 August 2016

Young Investigator's Program

12th Annual ENTELLIGENCE™ Young Investigator Program


2016-2017 Timeline

Letter of Intent (LOI) Submission: Sept. 15 – Nov. 3, 2016

LOI Review: Nov. 7 – Dec. 2, 2016

Grant Submission: Dec. 14, 2016 – Jan. 30, 2017

Grant Review: Feb. 1 – 20, 2017

Selection Meeting: February 27, 2017

Notify Applicants: March 20, 2017

Established in 2005, the program provides opportunities for promising young investigators to promote quality medical care and enhance patients’ lives by supporting research (basic science, clinical, or translational) in the area of pulmonary hypertension (PH), specifically related to expanding knowledge of pulmonary vascular pathobiology pathways. The ENTELLIGENCE program is led by a Steering Committee comprised of leaders in the field of pulmonary vascular disease.

Award winners receive a research grant of up to $100,000 to fund a 12-month mentored project.

ENTELLIGENCE investigations expand our knowledge of pulmonary vascular disease pathways which will, ultimately, improve treatment of patients with pulmonary hypertension.

Junior faculty members (up to and including the rank of Assistant Professor), post-doctoral students, research assistants, doctoral candidates, and fellows in the US and Canada are eligible.

Grants are awarded by a Steering Committee of leaders in the pulmonary hypertension field. Grading is based on scientific merit, originality, feasibility, mentorship, and applicability to the diagnosis and treatment of pulmonary hypertension.

Grants will be awarded to qualified investigators who show promise in basic science, clinical, or translational investigations of the mechanisms and/or vascular biology of pulmonary hypertension.

Click here for a message from Dr. Ronald J. Oudiz, ENTELLIGENCE Steering Committee Chairman.

Please visit http://www.ENTELLIGENCEMD.org for more information and to apply.

Comments (0)

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI